Cited 9 time in
Chitosan-Integrated Curcumin-Graphene Oxide/Copper Oxide Hybrid Nanocomposites for Antibacterial and Cytotoxicity Applications
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Sanmugam, Anandhavelu | - |
| dc.contributor.author | Sellappan, Logesh Kumar | - |
| dc.contributor.author | Sridharan, Abbishek | - |
| dc.contributor.author | Manoharan, Swathy | - |
| dc.contributor.author | Sairam, Ananda Babu | - |
| dc.contributor.author | Almansour, Abdulrahman I. | - |
| dc.contributor.author | Veerasundaram, Subha | - |
| dc.contributor.author | Kim, Hyun-Seok | - |
| dc.contributor.author | Vikraman, Dhanasekaran | - |
| dc.date.accessioned | 2024-08-08T14:00:53Z | - |
| dc.date.available | 2024-08-08T14:00:53Z | - |
| dc.date.issued | 2024-07 | - |
| dc.identifier.issn | 2079-6382 | - |
| dc.identifier.issn | 2079-6382 | - |
| dc.identifier.uri | https://scholarworks.dongguk.edu/handle/sw.dongguk/22804 | - |
| dc.description.abstract | This study deals with the facile synthesis of a single-pot chemical technique for chitosan-curcumin (CUR)-based hybrid nanocomposites with nanostructured graphene oxide (GO) and copper oxide (CuO) as the antibacterial and cytotoxic drugs. The physicochemical properties of synthesized hybrid nanocomposites such as CS-GO, CS-CuO, CS-CUR-GO, and CS-CUR-GO/CuO were confirmed with various advanced tools. Moreover, the in vitro drug release profile of the CS-CUR-GO/CuO nanocomposite exhibited sustained and controlled release during different time intervals. Also, the antibacterial activity of the CS-CUR-GO/CuO hybrid nanocomposite presented the maximum bactericidal effect against Staphylococcus aureus and Escherichia coli pathogens. The hybrid nanocomposites revealed improved cytotoxicity behaviour against cultured mouse fibroblast cells (L929) via cell adhesion, DNA damage, and proliferation. Thus, the chitosan-based hybrid nanocomposites offer rich surface area, biocompatibility, high oxidative stress, and bacterial cell disruption functionalities as a potential candidate for antibacterial and cytotoxicity applications. | - |
| dc.format.extent | 15 | - |
| dc.language | 영어 | - |
| dc.language.iso | ENG | - |
| dc.publisher | Multidisciplinary Digital Publishing Institute (MDPI) | - |
| dc.title | Chitosan-Integrated Curcumin-Graphene Oxide/Copper Oxide Hybrid Nanocomposites for Antibacterial and Cytotoxicity Applications | - |
| dc.type | Article | - |
| dc.publisher.location | 스위스 | - |
| dc.identifier.doi | 10.3390/antibiotics13070620 | - |
| dc.identifier.scopusid | 2-s2.0-85199622557 | - |
| dc.identifier.wosid | 001276685600001 | - |
| dc.identifier.bibliographicCitation | Antibiotics, v.13, no.7, pp 1 - 15 | - |
| dc.citation.title | Antibiotics | - |
| dc.citation.volume | 13 | - |
| dc.citation.number | 7 | - |
| dc.citation.startPage | 1 | - |
| dc.citation.endPage | 15 | - |
| dc.type.docType | Article | - |
| dc.description.isOpenAccess | Y | - |
| dc.description.journalRegisteredClass | scie | - |
| dc.description.journalRegisteredClass | scopus | - |
| dc.relation.journalResearchArea | Infectious Diseases | - |
| dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
| dc.relation.journalWebOfScienceCategory | Infectious Diseases | - |
| dc.relation.journalWebOfScienceCategory | Pharmacology & Pharmacy | - |
| dc.subject.keywordPlus | NANOPARTICLES | - |
| dc.subject.keywordPlus | BEHAVIOR | - |
| dc.subject.keywordAuthor | chitosan | - |
| dc.subject.keywordAuthor | graphene oxide | - |
| dc.subject.keywordAuthor | curcumin | - |
| dc.subject.keywordAuthor | CuO | - |
| dc.subject.keywordAuthor | antibacterial | - |
| dc.subject.keywordAuthor | cytotoxicity | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
30, Pildong-ro 1-gil, Jung-gu, Seoul, 04620, Republic of Korea+82-2-2260-3114
Copyright(c) 2023 DONGGUK UNIVERSITY. ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.
